Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test

Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test

Bibliographic Details
Main Authors: Tim Waterboer, Nicole Brenner, Jens P. Klussmann, Paul Brennan, Ulrike Wieland, Hilary A. Robbins
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:EBioMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396420305193
id doaj-609ed27ea41d4a1db5d191877136606c
record_format Article
spelling doaj-609ed27ea41d4a1db5d191877136606c2020-12-11T04:22:30ZengElsevierEBioMedicine2352-39642020-12-0162103143Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening testTim Waterboer0Nicole Brenner1Jens P. Klussmann2Paul Brennan3Ulrike Wieland4Hilary A. Robbins5Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Corresponding author.Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, GermanyDepartment of Otorhinolaryngology, Head and Neck Surgery, Medical Faculty, University of Cologne, Cologne, GermanyGenetic Epidemiology Group, International Agency for Research on Cancer, Lyon, FranceNational Reference Center for Papilloma- and Polyomaviruses, University of Cologne, Cologne, GermanyGenetic Epidemiology Group, International Agency for Research on Cancer, Lyon, Francehttp://www.sciencedirect.com/science/article/pii/S2352396420305193
collection DOAJ
language English
format Article
sources DOAJ
author Tim Waterboer
Nicole Brenner
Jens P. Klussmann
Paul Brennan
Ulrike Wieland
Hilary A. Robbins
spellingShingle Tim Waterboer
Nicole Brenner
Jens P. Klussmann
Paul Brennan
Ulrike Wieland
Hilary A. Robbins
Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test
EBioMedicine
author_facet Tim Waterboer
Nicole Brenner
Jens P. Klussmann
Paul Brennan
Ulrike Wieland
Hilary A. Robbins
author_sort Tim Waterboer
title Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test
title_short Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test
title_full Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test
title_fullStr Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test
title_full_unstemmed Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test
title_sort study results and related evidence do not support use of hpv16 l1 drh1 antibodies as a cancer screening test
publisher Elsevier
series EBioMedicine
issn 2352-3964
publishDate 2020-12-01
url http://www.sciencedirect.com/science/article/pii/S2352396420305193
work_keys_str_mv AT timwaterboer studyresultsandrelatedevidencedonotsupportuseofhpv16l1drh1antibodiesasacancerscreeningtest
AT nicolebrenner studyresultsandrelatedevidencedonotsupportuseofhpv16l1drh1antibodiesasacancerscreeningtest
AT jenspklussmann studyresultsandrelatedevidencedonotsupportuseofhpv16l1drh1antibodiesasacancerscreeningtest
AT paulbrennan studyresultsandrelatedevidencedonotsupportuseofhpv16l1drh1antibodiesasacancerscreeningtest
AT ulrikewieland studyresultsandrelatedevidencedonotsupportuseofhpv16l1drh1antibodiesasacancerscreeningtest
AT hilaryarobbins studyresultsandrelatedevidencedonotsupportuseofhpv16l1drh1antibodiesasacancerscreeningtest
_version_ 1724386899855933440

Similar Items